A transient improvement in renal function occurs after ischemic stroke

Renal Failure

Volumn 34, Issue 1, 2012, Pages 7-12

  Haider, Dominik Georg ^a   Ferrari, Julia ^a   Mittermayer, Friedrich ^a,b   Wolzt, Michael ^a   Hörl, Walter Hermann ^a   Lalouschek, Wolfgang ^a   Lang, Wilfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

Author keywords

Ischemia; Kidney function; Neurohumoral; Stroke

Indexed keywords

CREATININE;

AGED; ARTICLE; BRAIN ISCHEMIA; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; BRAIN ISCHEMIA; CHRONIC DISEASE; COHORT STUDIES; CREATININE; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; PROSPECTIVE STUDIES; STROKE; TIME FACTORS;

EID: 84055193364     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.623439     Document Type: Article

References (28)

1. Cuadra AE, Shan Z, Sumners C, Raizada MK. A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? Pharmacol Ther. 2010;125:27-38.
2. DiBona GF. The sympathetic nervous system and hypertension: Recent developments. Hypertension. 2004;43:147-150. (Pubitemid 38174164)
3. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75-197. (Pubitemid 27069290)
4. Wyss JM, Oparil S, Sripairojthikoon W. Neuronal control of the kidney: Contribution to hypertension. Can J Physiol Pharmacol. 1992;70:759-770.
5. O'Hagan KP, Thomas GD, Zambraski EJ. Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension. Am J Hypertens. 1990;3:62-64. (Pubitemid 20077356)
6. Alexander BT, Hendon AE, Ferril G, Dwyer TM. Renal denervation abolishes hypertension in low-birth-weight offspring from pregnant rats with reduced uterine perfusion. Hypertension. 2005;45:754-758. (Pubitemid 40418377)
7. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension. 1995;25: 893-897.
8. Sykora M, Diedler J, Turcani P, Hacke W, Steiner T. Baroreflex: A new therapeutic target in human stroke? Stroke. 2009;40:e678-e682.
9. Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2010;9:105-118.
10. Tikhonoff V, Zhang H, Richart T, Staessen JA. Blood pressure as a prognostic factor after acute stroke. Lancet Neurol. 2009;8:938-948.
11. Harrigan M. Cerebral salt wasting syndrome: A review. Neurosurgery. 1996;38:152-160. (Pubitemid 26002394)
12. Amer M, Haase J, Bie P, Holmegaard SN, Djurberg H. Cerebral salt wasting syndrome and syndrome of inappropriate antidiuretic hormone secretion in subarachnoid hemorrhage caused by ruptured berry aneurysms. Pan Arab J Neurosurg. 2000;4:25-31.
13. Lang W, Lalouschek W, for the Vienna Stroke Study Group. The Vienna Stroke Registry-Objectives and methodology. Wien Klin Wochenschr. 2001;113:141-147.
14. Lalouschek W, Lang W, Muellner M. Current strategies of secondary prevention after a cerebrovascular event: The Vienna Stroke Registry. Stroke. 2001;32:2860-2866. (Pubitemid 33134480)
15. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: An occult burden. Adv Chronic Kidney Dis. 2008;15:123-132. (Pubitemid 351343871)
16. Seliger SL, Longstreth Jr, WT. Lessons about brain vascular disease from another pulsating organ, the kidney. Stroke. 2008;39:5-6.
17. Khatri M, Wright CB, Nickolas TL, et al. Chronic kidney disease is associated with white matter hyperintensity volume. The Northern Manhattan Study (NOMAS). Stroke. 2007;38: 3121-3126. (Pubitemid 350175724)
18. Yang XL, So WY, Kong AP, et al. Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: The Hong Kong Diabetes Registry. Diabetes Care. 2007;30:65-70. (Pubitemid 46052501)
19. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689. (Pubitemid 32893993)
20. Yang X, So WY, Tong PC, et al. Development and validation of an all-cause mortality risk score in type 2 diabetes: The Hong Kong Diabetes Registry. Arch Intern Med. 2008;168:451-457. (Pubitemid 351547208)
21. Krumholz HM, Chen YT, Vaccarino V, et al. Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. Am J Cardiol. 2000;85:1110-1113. (Pubitemid 30214258)
22. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61-67. (Pubitemid 38045917)
23. Mielniczuk LM, Pfeffer MA, Lewis EF, et al. Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. Clin J Am Soc Nephrol. 2009;4: 1811-1817.
24. Melin J, Hellberg O, Fellström B. Hyperglycaemia and renal ischemia-reperfusion injury. Nephrol Dial Transplant. 2003;18:460-462.
25. Rizvi AA. Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: Emerging concepts. Am J Med Sci. 2009;338:310-318.
26. von Haehling S, Schefold JC, Lainscak M, Doehner W, Anker SD. Inflammatory biomarkers in heart failure revisited: Much more than innocent bystanders. Heart Fail Clin. 2009;5: 549-560.
27. Iadecola C, AlexanderM. Cerebral ischemia and inflammation. Curr Opin Neurol. 2001;14:89-94. (Pubitemid 32116263)
28. Liu M, Dziennis S, Hurn PD, Alkayed NJ. Mechanisms of gender-linked ischemic brain injury. Restor Neurol Neurosci. 2009;27:163-179.